Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

by

Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice models.

Leave A Comment

Your email address will not be published. Required fields are marked *